Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
Several approaches have produced an effective vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Since millions of people are exposed to influenza …
syndrome coronavirus 2 (SARS-CoV-2). Since millions of people are exposed to influenza …
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor …
JM Patel, VF Vartabedian, EN Bozeman, BE Caoyonan… - Biomaterials, 2016 - Elsevier
Antigen delivered within particulate materials leads to enhanced antigen-specific immunity
compared to soluble administration of antigen. However, current delivery approaches for …
compared to soluble administration of antigen. However, current delivery approaches for …
Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses
JM Patel, MC Kim, VF Vartabedian, YN Lee… - … , Biology and Medicine, 2015 - Elsevier
Recombinant virus-like nanoparticles (VLPs) are a promising nanoparticle platform to
develop safe vaccines for many viruses. Herein, we describe a novel and rapid protein …
develop safe vaccines for many viruses. Herein, we describe a novel and rapid protein …